Large granular lymphocytes that strongly express CD56 (CD56 ϩϩ LGL) constitute a major population of leukocytes in the secretory endometrium and pregnancy decidua and are considered to be involved in reproductive immunity and in maintaining the pregnancy. The present study aimed to reveal the relationship between the characteristic changes of CD56 ϩϩ LGL and altered hormonal environment and/ or trophoblast invasion in the endometrium. Cell surface markers of CD56 ϩϩ LGL obtained from the endometrium during the menstrual cycle and early pregnancy were analysed using flow cytometry. The percentages of both CD56 ϩϩ LGL that express activation antigens (CD69, HLA-DR) and those that express lymphocyte function associated antigen-1 (LFA-1) (CD11a/CD18) were highest in the proliferative phase and decreased gradually throughout the menstrual cycle. Expression of these antigens was further suppressed in the late secretory phase, as well as in the early stage of pregnancy. However, the percentage of CD56 ϩϩ LGL that express these antigens was significantly higher in spontaneous abortions than in normal pregnancies. On the other hand, the percentage of CD56 ϩϩ LGL that express CD45RA was lower during normal pregnancy than during the menstrual cycle. The present results suggest that characteristics alterations of CD56 ϩϩ LGL are regulated by altered hormonal environment and by trophoblast invasion.
Introduction
A large number of maternal large granular lymphocytes (LGL) appear in the endometrium at embryonic implantation (King et al., 1989a; Bulmer et al., 1991) . The LGL (CD56-bright and CD16-negative; CD56 ϩϩ LGL) are distinguished phenotypically and functionally from peripheral blood natural killer (NK) cells (CD56-positive and CD16-positive; CD56 ϩ NK cells) (Starkey et al., 1988; Naglar et al., 1989; Nishikawa et al., 1991; King et al., 1992) , and are considered as an immature form of NK cell differentiation (Naglar et al., 1989) .
However, the role of these lymphocytes at implantation and early placentation remains unclear. As a majority of CD56 ϩϩ LGL in early pregnancy decidua express the activation antigen marker CD69 (Nishikawa et al., 1991) and very late antigen 1 (VLA-1) (Dietl et al., 1992) , they are considered to be activated by factors subject to hormonal influence and/or by trophoblast invasion (Dietl et al., 1992) . Furthermore, they may play a role in the control of migration and differentiation of trophoblasts through secreting various cytokines (Nishikawa et al., 1991; Dietl et al., 1992) . These decidual CD56 ϩϩ LGL also exhibit NK-like cytotoxic activity against the K562 cell line (King et al., 1989; Manaseki and Searle, 1989; Ritson and Bulmer, 1989; Ferry et al., 1990; Nishikawa et al., 1991) , although the level of cytotoxicity is lower than that in peripheral blood CD56 ϩ NK cells (King et al., 1989b) . However, it is known that decidual CD56 ϩϩ LGL acquire the cytotoxic activity of cultured trophoblasts after in-vitro stimulation by IL-2 (King and Loke, 1990) . Such stimulation to the maternal immune system could result in rejection of the fetus, unless the decidual CD56 ϩϩ LGL can be regulated in order to protect the trophoblasts at the feto-maternal interface.
In the early pregnancy decidua, CD56 ϩϩ LGL reside in close apposition to invasive fetal trophoblasts. Moreover, immunohistochemical analysis of the endometrium throughout the menstrual cycle has demonstrated hormone-dependent accumulation and survival of CD56 ϩϩ LGL (King et al., 1989a; Bulmer et al., 1991) . These findings indicate that altered hormonal environment and/or trophoblast invasion might affect CD56 ϩϩ LGL in the endometrium and decidua, both in quantity and quality.
In the present study, we examined cell surface markers on CD56 ϩϩ LGL in early pregnant decidua and in non-pregnant endometrium in order to clarify when characteristic changes in the LGLs occur. We then examined the relationship between these changes and altered hormonal environment and/or trophoblast invasion in the endometrium.
Materials and methods

Tissues
Twenty-eight endometria were obtained from hysterectomy specimens of non-pregnant patients of reproductive age (Ͻ45 years old) who had no menstrual problems; hysterectomy was performed for myoma uteri or adenomyosis without endometrial pathology. Only specimens which were histologically normal were included in the study. The endometria were dated according to the criteria published by Noyes et al. (1950) and were categorized as being in the proliferative (n ϭ 14), in the early secretory (days 14-21; n ϭ 6) or in the late secretory phase (day 22 onwards; n ϭ 8) of the menstrual cycle. Data are presented as mean Ϯ SD (%) of the frequency in CD45-positive cell population. Frequencies followed by letters are significantly different from each other: a,b P Ͻ 0.01; c P Ͻ 0.05. Decidual samples from 14 normal pregnant women were obtained following legal termination during 6-9 weeks of gestation. In all cases, the fetal heart beat was detected by trans-vaginal ultrasonography.
Decidual samples from spontaneous abortions during 6-10 weeks of gestation were obtained from 21 women who were diagnosed with an incomplete abortion by ultrasonography. Three were recurrent cases.
Peripheral blood samples were obtained from three uneventful pregnancies at 6-9 weeks of gestation.
Preparation of endometrial and decidual lymphocyte suspensions
In order to minimize changes in the surface markers, lymphocyte separation was performed as soon as possible after sampling of the specimens, and to avoid the influence of the enrichment procedure on the surface markers, we selected mechanical rather than enzymatic dispersal for preparation of lymphocyte suspensions.
Tissue fragments were washed with cold phosphate-buffered saline (PBS, 0.015, pH 7.2) and minced into 1-2 mm pieces with scissors. These samples were pressed through a stainless steel sieve three times (50, 80, 150 mesh) and then centrifuged over a two-step density (density: 1.040/1.083) Percoll gradient (Pharmacia Fine Chemicals, Uppsala, Sweden) at 400 g for 30 min to remove decidual or endometrial cells and dead cells. The enriched mononuclear cell suspensions were then washed twice with PBS containing 0.1% bovine serum albumin (PBS/BSA).
Preparation of peripheral blood lymphocyte (PBL) suspensions
PBLs were isolated from heparinized venous blood samples by FicollHypaque gravity centrifugation.
Flow cytometry
Monoclonal antibodies labelled with fluorescein isothiocyanate (FITC) or phycoerythrin (PE) were used for direct immunofluorescence. The following monoclonal antibodies (mAb), purchased from Becton Dickinson Immunocytometry Systems (San José, CA, USA), were used: anti-Leu-4 (CD3), anti-HLe-1 (CD45), anti-Leu-18 (CD45RA), anti-Leu-19 (CD56), anti-Leu-23 (CD69), anti-Leu-5b (CD2), anti-LFA-1α (CD11a), anti-LFA-1β (CD18) and anti-HLA-DR (HLA-DR). Anti-UCHL-1 (CD45RO) mAb was obtained from Nichirei (Tokyo, Japan).
Approximately 2ϫ10 ANOVA (Scheffé's F) and the Wilcoxon Mann-Whitney test were used for statistical evaluation. Significance was established at the P Ͻ 0.05 level.
Results
Leukocyte subpopulations in endometrium during the menstrual cycle and early pregnancy Leukocyte subpopulations in endometrial infiltrating cells are summarized as a proportion in the total CD45 ϩ cell population (Table I ). The frequency of CD56 ϩϩ LGL in early pregnancy was significantly higher than that in the proliferative or early secretory phase. In contrast, the frequency of CD3 ϩ T cells was significantly lower in early pregnancy than in the proliferative or early secretory phase. An increase in CD56 ϩϩ LGL frequency in association with the decrease in CD3 ϩ T cell frequency was observed during progression of the menstrual cycle from the proliferative phase to the late secretory phase. There was a slight change in the frequency of CD20 ϩ B cells and CD14 ϩ monocyte/macrophages and no change in the frequency of CD56 ϩ NK cells during the menstrual cycle and early pregnancy. The frequency of CD3 ϩ T cells was higher and that of CD14 ϩ monocyte/macrophages was lower in the present study than those in previous reports (Starkey et al., 1988; King et al., 1991) . This discrepancy may be due to the difference of markers (HLA-DR versus CD14 for monocyte markers) or separation technique (enzymatic treatment versus mechanical separation, and/or density of Percoll versus density of Lymphoprep) used in these studies.
Phenotype of peripheral blood CD56 ϩϩ LGL and decidual CD56 ϩϩ LGL in normal pregnancy
The expression of activation antigens, CD45 isoforms and LFAs of CD56 ϩϩ LGL in peripheral blood and normal Figure 1 . Two-colour flow-cytometric analysis of expression of activation antigens (CD69, HLA-DR) (1), CD45 isoforms (CD45RA, CD45RO) (2) and LFAs (CD2, CD11a, CD18) (3) in CD56 ϩϩ LGL in peripheral blood and in early pregnancy decidua. PBL and decidual lymphocytes were analysed using a FACScan. The CD56 ϩϩ LGL fraction was gated, and expression of antigens was displayed histographically. The horizontal and vertical axes represent log fluorescence intensity and relative number of cells, respectively. Dotted lines show background fluorescence determined using a fluorescein-labelled control mouse IgG1.
pregnancy decidua was analysed (Table II) . Representative flow patterns of these samples are shown in Figure 1 . The majority of CD56 ϩϩ LGL in peripheral blood expressed HLA-DR (66.2 Ϯ 3.8%) but little CD69 (2.1 Ϯ 2.1%). In contrast, 1038 the CD56 ϩϩ LGL in normal pregnancy decidua expressed CD69 at a frequency of 28.2 Ϯ 12.0% but little if any HLA-DR (8.2 Ϯ 4.8%). With respect to CD45 isoforms, most of the CD56 ϩϩ LGL in peripheral blood were CD45RA ϩ cells LGL that express activation antigens CD69, HLA-DR (1), CD45 isoforms (CD45RA, CD45RO) (2) and LFAs (CD2, CD11a and CD18) (3) in endometrium throughout the menstrual cycle (proliferative phase, proliferative; early secretory phase, early sec.; late secretory phase, late sec.) and early pregnancy (early preg.). Data appear as box plots and the five horizontal lines associated with each category represent the 10th, 25th, 50th, 75th and 90th percentiles. **P Ͻ 0.01, *P Ͻ 0.05.
(96.8 Ϯ 2.9%). However, approximately half of the CD56 ϩϩ LGL in normal pregnancy decidua expressed CD45RA (50.3 Ϯ 17.4%). Almost all of the CD56 ϩϩ LGL (99.9 Ϯ 0.1%) in peripheral blood expressed CD11a or CD18, whereas approximately half of the CD56 ϩϩ LGL (51.8 Ϯ 23.7%, 54.3 Ϯ 23.0%) in normal pregnancy decidua expressed these antigens. These results indicate that a substantial proportion of the CD56 ϩϩ LGL in pregnancy decidua were primed and activated by some stimuli and that LFA-1 expression in these cells was modulated.
Regulation of expression of activation antigens, CD45 isoforms and LFA-s in CD56 ϩϩ LGL during the menstrual cycle and early pregnancy The percentage of CD56 ϩϩ LGL expressing activation antigens and those expressing CD45 isoforms was examined in normal pregnancy decidua and in endometrium (Figure 2) . Expression of activation antigens such as CD69 and HLA-DR showed the highest percentage in the proliferative phase, 66.3 Ϯ 12.8 and 19.2 Ϯ 9.4% respectively, and decreased gradually along with the menstrual cycle. The percentage of both was significantly lower in the early stage of pregnancy than in the proliferative phase (P Ͻ 0.01). Expression of CD45RA showed its lowest percentage at the early stage of pregnancy compared with the early or late secretory phase. With respect to CD45RO, no significant trend was observed. Of the CD56 ϩϩ LGL, 50.3 Ϯ 17.4% expressed CD45RA and 44.8 Ϯ 15.4% expressed CD45RO positivity in the early stage of pregnancy.
The percentage of CD56 ϩϩ LGL that expressed LFAs was also examined (Figure 2 ). In the proliferative phase, the percentages of CD11a positive or CD18 positive CD56 ϩϩ LGL were 91.2 Ϯ 5.6 and 92.6 Ϯ 4.8% respectively. However, in the early stage of pregnancy, they were only 51.8 Ϯ 23.7 and 54.3 Ϯ 23.0% respectively. In addition, the percentage decreased gradually as the menstrual cycle progressed from the proliferative phase to the late secretory phase, reaching a minimal value in the early stage of pregnancy. CD2 expression did not change during these phases.
A positive correlation was observed between the percentage of CD56 ϩϩ LGL that expressed CD45RA and LGLs that expressed CD11a ( Figure 3A) . A positive correlation was also observed between the percentage of CD56 ϩϩ LGL that expressed CD45RA and LGLs that expressed CD18 ( Figure  3B ). These correlations suggest that CD56 ϩϩ LGL are primed in the endometrium and decidua and then lose expression of CD11a/CD18.
Expression of activation antigens, CD45 isoforms and LFA-s in decidual CD56 ϩϩ LGL in normal pregnancy and spontaneous abortions
The percentage of CD56 ϩϩ LGL that express activation antigens, CD45 isoforms and LFAs in the decidua of 21 cases of spontaneous abortions was compared to that of 14 cases of normal pregnancy (Figure 4) . Among the spontaneous abortion cases, five out of nine cases examined showed chromosome abnormalities in villi but there was no significant difference 1040 in cell surface marker expression on CD56 ϩϩ LGL in these cases (data not shown). A significantly greater number of
LGLs expressed activation antigens such as CD69 and HLA-DR in spontaneous abortions than in normal pregnancy (P Ͻ 0.05). Similarly, a significantly greater number of LGLs expressed CD11a and CD18 in the spontaneous abortions than in the normal pregnancies (P Ͻ 0.05). However, the expression of CD2, CD45RA and CD45RO did not show any significant differences among the groups.
Discussion
The characteristic expression of surface markers of CD56 ϩϩ LGL in the endometrium, analysed in the present study, was modulated during the menstrual cycle and early pregnancy. The percentage of CD56 ϩϩ LGL that expressed CD69 and HLA-DR was highest in the proliferative phase, decreased gradually along with the menstrual cycle, and then plateaued in early pregnancy. Similarly, the percentage of CD56 ϩϩ LGL that expressed CD11a (α-chain of LFA-1) and CD18 (β-chain of LFA-1), which represent the most important receptors for mediating primary adhesion and the cytotoxic activity of NK cells (Nishimura et al., 1985 (Nishimura et al., , 1987 Ritz et al., 1988; Robertson et al., 1990) , changed throughout the menstrual cycle. CD56 ϩϩ LGL are reportedly activated in early pregnancy decidua, and thus are considered to play a role in placentation (Nishikawa et al., 1991; Dietl et al., 1992; Mincheva-Nilsson et al., 1994) . However, the present study revealed that CD56 ϩϩ LGL have already been activated in the endometrium prior to ovum implantation and are unlikely to have been stimulated primarily as a result of contact with trophoblasts. Thus, these results suggest that CD56 ϩϩ LGL may play an important role not only in reproductive immunity but also in the primary local defence against infection in the menstrual cycle endometrium. More interestingly, expression of activation antigens (CD69, HLA-DR) and LFA-1 (CD11a/CD18) was suppressed in the secretory endometrium, suggesting that functional regulation of CD56 ϩϩ LGL may occur in the secretory endometrium. As previous studies have reported that CD56 ϩϩ LGL express Ki67 and proliferate in the mid-to late secretory endometrium LGL that express activation antigens (1), CD45 isoforms (2) and LFAs (3) in decidua of normal pregnancies and spontaneous abortions. Data appear as box plots and the five horizontal lines associated with each category represent the 10th, 25th, 50th, 75th and 90th percentiles. **P Ͻ 0.01, *P Ͻ 0.05. (Pace et al., 1989) , expression of activation antigens and LFA-1 in CD56 ϩϩ LGL may be down-regulated while the cell proliferates. Therefore, the down-regulation of the expression of these antigens in the secretory endometrium may be advantageous for success of implantation despite the fact that local defence may be suppressed.
The percentage of CD56 ϩϩ LGL expressing CD45RA was lower in the early pregnancy decidua than in the early and late secretory endometrium. However, there was no change in this percentage throughout the menstrual cycle. Since in-vitro activation of CD45RA ϩ CD45RO -NK cells results in the acquisition of CD45RO expression and loss of CD45RA expression, CD45RA -CD45RO ϩ NK cells appear to be more functionally hyper-reactive and differentiated than CD45RA ϩ CD45RO -NK cells (Braakmann et al., 1991) . Furthermore, CD56 ϩϩ LGL in early pregnancy decidua produce a greater variety of cytokines than those in peripheral blood (Saito et al., 1993; Jokhi et al., 1994) . Since most CD56 ϩϩ LGL in early pregnancy decidua were CD45RA -CD45RO ϩ , these cells may have been functionally hyper-reactive and differentiated 'primed' cells as a result of stimulation by some interaction with trophoblasts.
Recent studies have suggested that trophoblasts are protected from NK cell mediated lysis by the expression of HLA-G on their surfaces (Pazmany et al., 1996) . Indeed, trophoblasts are resistant to cytolysis by peripheral blood NK cells and freshly isolated decidual CD56 ϩϩ LGL (King et al., 1989b) . Furthermore, the cytotoxic activity of freshly isolated CD56 ϩϩ LGL from early pregnancy decidua is lower than that of NK cells in the peripheral blood (King et al., 1989b) , although the decidual LGLs acquire cytotoxic activity against trophoblasts when they are treated with IL-2 (King and Loke, 1990) . Another study revealed that IL-2 stimulation not only restores the cytotoxic activity but also increases the expression of CD11a/CD18 (LFA-1) in the LGLs (Burrows et al., 1993) , suggesting a positive correlation between cytotoxic activity and LFA-1 expression. Thus, down-regulation of LFA-1 expression may play an important role in controlling the cytotoxic activity of decidual CD56 ϩϩ LGL. The results of our study demonstrate that the percentage of CD56 ϩϩ LGL that express LFA-1, CD69 and HLA-DR is higher in decidua of spontaneous abortions than in normal pregnancies. Although the change in the immunophenotype of the LGLs seen in spontaneous abortions could be secondary to tissue degradation and necrosis associated with this condition, these results raise the possibility that down-regulation of expression of these antigens, especially LFA-1, in CD56 ϩϩ LGL in normal pregnancy decidua may be crucial for maintaining the pregnancy.
The present study, as well as previous studies, has demonstrated that the number of CD56 ϩϩ LGL increases in the midto late secretory phase of the cycle, suggesting the involvement of progesterone in the proliferation and/or migration of these cells (King et al., 1989a; Bulmer et al., 1991) . These findings also suggest that the down-regulation of expression of activation antigens and LFA-1 in CD56 ϩϩ LGL may be associated with changes in the hormonal environment of the secretory endometrium. However, the oestrogen receptor (ER) and progesterone receptor (PR) are not expressed in CD56 ϩϩ LGL. Furthermore, endometrial stromal cells are the only cells that express PR in the secretory phase and in early pregnancy (King et al., 1996) . Since endometrial stromal cells differentiate under the influence of oestrogen and progesterone in the secretory phase prior to implantation, changes both in the secretion of soluble products and in the extracellular matrix (ECM) assembly of the endometrium and decidua appear to be essential for the control of CD56 ϩϩ LGL, as suggested by Loke and King (1995) . CD56 ϩϩ LGL are reported to express α5β1, α4β7 (receptors for fibronectin) and α4β1 (a receptor for VCAM-1 and fibronectin) (Burrows et al., 1993 (Burrows et al., , 1995 . Endometrial stromal cells are reported to express ICAM-1 (ligand of LFA-1) and VCAM-1 (Tabibzadeh and Poubouridis, 1990 , Marzusch et al., 1993 , Ruck et al., 1994 . Decidual CD56 ϩϩ LGL were found to bind strongly to decidual stromal cells, fibronectin, and collagen in vitro (Burrows et al., 1995) . Furthermore, integrin-mediated ECM interaction of T cells can regulate cellular functions such as proliferation, differentiation and cytokine secretion (Hemler, 1991; Hynes, 1992) . These findings suggest that decidual stromal cells may regulate the 1042 function of CD56 ϩϩ LGL both by direct interaction through the ECM and by indirect interaction through the secretion of soluble factors.
The present results also suggest a positive correlation between frequency of CD11a/CD18 (LFA-1) expression and that of CD45RA expression in CD56 ϩϩ LGL. Since the expression of CD45RA is known to be lost upon stimulation, this positive correlation indicates that the expression of LFA-1 might be down-regulated by some stimulatory signals in the secretory endometrium and in early pregnancy decidua. These stimulatory signals may be essential for the maintenance of pregnancy through the suppression of the cytotoxic activity by down-regulation of LFA-1 expression.
Recently, Krasnow et al. (1996) reported that the secretion of type 2 T-helper (Th2) cytokines, IL-4, IL-5, IL-6, and IL-10 increases in the secretory endometrium and early pregnancy decidua, suggesting that Th-2 cytokine-mediated down-regulation of cellular immunity plays a role in the maintenance of pregnancy. Further, Marzusch et al. (1997) have shown that Th-1 cytokines, IL-2 and IL-12 synergistically stimulate IFN-γ production by decidual LGLs through an interaction with macrophages, suggesting that decidual macrophages control promotion of Th-1-biased immunity which is considered to have an inhibitory effect on conceptus development. It is of interest to investigate how the cytokine profile in the endometrium is involved in down-regulation of LFA-1 expression in CD56 ϩϩ LGL, for a better understanding of the mechanisms of immune regulation in pregnancy. Further studies on mechanisms by which CD56 ϩϩ LGL function is modulated in the secretory endometrium are necessary.
